A high-performance liquid chromatographic method for the simultaneous determination of KR-008 and its metabolite in biological fluids was developed The samples were injected directly without further treatment,the comp...A high-performance liquid chromatographic method for the simultaneous determination of KR-008 and its metabolite in biological fluids was developed The samples were injected directly without further treatment,the compounds were separated and analysed on a reversed- phase column under isocratic conditions,including ion pairing.Concentrations in urine and bile were determined by an external standard method.The detection limit was 0.8μg/ml in urine.Preliminary data showed that,following i.p.administration(120mg/kg)of KR-008 to rats,approximately 2.8% of the dose was excreted in urine as unchanged compound and more than 8.9% was as a metabolite;in bile it was 0.73% excreted as unchanged form and above 0.29% as the metabolite.The peak biliary concentration of KR-008 was 0.39mg/ml at 20min after dosing.展开更多
文摘A high-performance liquid chromatographic method for the simultaneous determination of KR-008 and its metabolite in biological fluids was developed The samples were injected directly without further treatment,the compounds were separated and analysed on a reversed- phase column under isocratic conditions,including ion pairing.Concentrations in urine and bile were determined by an external standard method.The detection limit was 0.8μg/ml in urine.Preliminary data showed that,following i.p.administration(120mg/kg)of KR-008 to rats,approximately 2.8% of the dose was excreted in urine as unchanged compound and more than 8.9% was as a metabolite;in bile it was 0.73% excreted as unchanged form and above 0.29% as the metabolite.The peak biliary concentration of KR-008 was 0.39mg/ml at 20min after dosing.
